UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review

PloS one, 2016-03, Vol.11 (3), p.e0149160-e0149160

2016

Volltextzugriff (PDF)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

The Journal of infectious diseases, 2018-07, Vol.218 (3), p.355-364

2018

Volltextzugriff (PDF)

Measuring coverage in MNCH: total survey error and the interpretation of intervention coverage estimates from household surveys

PLoS medicine, 2013-05, Vol.10 (5), p.e1001386-e1001386

2013

Volltextzugriff (PDF)

Maternal HIV Infection and Placental Malaria Reduce Transplacental Antibody Transfer and Tetanus Antibody Levels in Newborns in Kenya

The Journal of infectious diseases, 2007-08, Vol.196 (4), p.550-557

2007

Volltextzugriff (PDF)

Immunogenicity of Standard-Titer Measles Vaccine in HIV-1-Infected and Uninfected Zambian Children: An Observational Study

The Journal of infectious diseases, 2007-08, Vol.196 (3), p.347-355

2007

Volltextzugriff (PDF)

Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad

PLoS medicine, 2007-01, Vol.4 (1), p.e16-e16

2007

Volltextzugriff (PDF)

The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants

Clinical infectious diseases, 2007-12, Vol.45 (11), p.1417-1424

2007

Volltextzugriff (PDF)

Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination

Vaccine, 2007-05, Vol.25 (21), p.4170-4174

2007

Volltextzugriff (PDF)

Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in the Gambia

The Pediatric infectious disease journal, 2006-08, Vol.25 (8), p.700-705

2006

Volltextzugriff (PDF)

Nasopharyngeal Carriage of Streptococcus pneumoniae in Gambian Children who Participated in a 9-valent Pneumococcal Conjugate Vaccine Trial and in Their Younger Siblings

The Pediatric infectious disease journal, 2009-11, Vol.28 (11), p.990-995

2009

Volltextzugriff (PDF)

HIV Type 1 Infection Is a Risk Factor for Mortality in Hospitalized Zambian Children with Measles

Clinical infectious diseases, 2008-02, Vol.46 (4), p.523-527

2008

Volltextzugriff (PDF)

Ensuring access to HPV vaccines through integrated services : a reproductive health perspective

Bulletin of the World Health Organization, 2007-01, Vol.85 (1), p.57-63

2007

Volltextzugriff (PDF)

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

The Lancet (British edition), 2000-03, Vol.355 (9206), p.798-803

2000

Volltextzugriff (PDF)

SUPPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD DURING ACUTE MEASLES

The Pediatric infectious disease journal, 2009-01, Vol.28 (1), p.63-65

2009

Volltextzugriff (PDF)

Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns

Vaccine, 2006-11, Vol.24 (49), p.7142-7147

2006

Volltextzugriff (PDF)

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting

International journal of epidemiology, 2005-06, Vol.34 (3), p.565-574

2005

Volltextzugriff (PDF)

Prospective Study of Measles in Hospitalized, Human Immunodeficiency Virus (HIV)—Infected and HIV—Uninfected Children in Zambia

Clinical infectious diseases, 2002-07, Vol.35 (2), p.189-196

2002

Volltextzugriff (PDF)

Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh

Bulletin of the World Health Organization, 2002-01, Vol.80 (10), p.776-782

2002

Volltextzugriff (PDF)

PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTES

The Pediatric infectious disease journal, 2000-12, Vol.19 (12), p.1211-1213

2000

Volltextzugriff (PDF)

Chapter 15: HPV vaccine use in the developing world

Vaccine, 2006-08, Vol.24, p.S132-S139

2006

Volltextzugriff (PDF)

Immune modulation after measles vaccination of 6–9 months old Bangladeshi infants

Vaccine, 2001-01, Vol.19 (11), p.1503-1510

2001

Volltextzugriff (PDF)

Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

Vaccine, 2016-03, Vol.34 (12), p.1459-1464

2016

Volltextzugriff (PDF)

Edmonston-Zagreb measles vaccine: A good vaccine with an image problem

Pediatrics (Evanston), 1999-11, Vol.104 (5 Pt 1), p.1123

1999

Volltextzugriff (PDF)

Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

The Journal of infectious diseases, 2008-11, Vol.198 (10), p.1457-1465

2008

Volltextzugriff (PDF)

HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus–Specific Immunoglobulin G after Vaccination and Infection

The Journal of infectious diseases, 2009-10, Vol.200 (7), p.1031-1038

2009

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(43)
Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Male
(33)
Infant
(30)
Infectious Diseases
(28)
Biological And Medical Sciences
(26)
Medical Sciences
(25)
Immunology
(24)
Measles
(23)
Child, Preschool
(22)
Antibodies, Viral - Blood
(16)
Child
(16)
Measles - Prevention & Control
(16)
Microbiology
(16)
Measles Virus - Immunology
(15)
Vaccination
(15)
Human Viral Diseases
(14)
Measles Vaccine - Administration & Dosage
(14)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Using Seroprevalence and Immunisation Coverage Data to Estimate the Global Burden of Congenital Rubella Syndrome, 1996-2010: A Systematic Review

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

Measuring coverage in MNCH: total survey error and the interpretation of intervention coverage estimates from household surveys

Maternal HIV Infection and Placental Malaria Reduce Transplacental Antibody Transfer and Tetanus Antibody Levels in Newborns in Kenya

Immunogenicity of Standard-Titer Measles Vaccine in HIV-1-Infected and Uninfected Zambian Children: An Observational Study

Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad

The Influence of HIV-1 Exposure and Infection on Levels of Passively Acquired Antibodies to Measles Virus in Zambian Infants

Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination

Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in the Gambia

Nasopharyngeal Carriage of Streptococcus pneumoniae in Gambian Children who Participated in a 9-valent Pneumococcal Conjugate Vaccine Trial and in Their Younger Siblings

HIV Type 1 Infection Is a Risk Factor for Mortality in Hospitalized Zambian Children with Measles

Ensuring access to HPV vaccines through integrated services : a reproductive health perspective

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

SUPPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD DURING ACUTE MEASLES

Levels of rubella antibody among vaccinated and unvaccinated Portuguese mothers and their newborns

An economic analysis of a pneumococcal vaccine programme in people aged over 64 years in a developed country setting

Prospective Study of Measles in Hospitalized, Human Immunodeficiency Virus (HIV)—Infected and HIV—Uninfected Children in Zambia

Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh

PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTES

Chapter 15: HPV vaccine use in the developing world

Immune modulation after measles vaccination of 6–9 months old Bangladeshi infants

Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

Edmonston-Zagreb measles vaccine: A good vaccine with an image problem

Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus–Specific Immunoglobulin G after Vaccination and Infection

Aktive Filter

Suchergebnisse filtern